Phase 4 Meningococcal Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
VaccinationTransgender PersonsMeningococcal Meningitis, Serogroup B+1 more
University Ghent250 enrolled1 locationNCT06832514
Not Yet Recruiting
Phase 4
Optimal Timing for Adolescent Meningococcal B vaccination schedule (BOOST MenB study)
Meningococcal immunityImmune Response to meningococcal vaccination
University of Adelaide284 enrolled1 locationACTRN12625001444471
Recruiting
Phase 4
A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
Meningitis, Meningococcal
GlaxoSmithKline50 enrolled10 locationsNCT06113198
Completed
Phase 4
MenGO: Does the licensed meningococcal vaccine Bexsero® provide cross- protection against gonorrhoea?
Gonorrhoea infectionMeningococcal B vaccine
Gold Coast Hospital and Health Service130 enrolled1 locationACTRN12619001478101
Completed
Phase 4
South Australian Meningococcal B Vaccine Herd Immunity Study in Adolescents
Neisseria meningitides nasopharyngeal carriageInvasive Meningococcal disease
The University of Adelaide44,000 enrolled1 locationACTRN12617000079347
Completed
Phase 4
Impact of conjugate versus polysaccharide quadrivalent ACWY vaccine on meningococcal carriage among Hajj pilgrims
meningococcal carriage
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), The Children's Hospital at Westmead1,780 enrolled2 locationsACTRN12616001230448